Perry stepped down effective Dec. 30 to join an unnamed biotechnology company as its CFO, according to a press release.
Becton Dickinson & Co. (NYSE:BDX) won FDA 510(k) clearance for its BD Veritor 10-minute diagnostic test for influenza A and B last month, amid rumors that the Franklin Lakes, N.J.-based company is ripe for buyout.
Veritor is the first rapid flu test with a digital readout, while older tests are slower, less accurate and more difficult to interpret, according to BD.
U.K.-based device maker Sphere Medical Holding Plc (AIM:SPHR) raised nearly $19 million (£14 million) on its first day trading on the AIM market of London’s stock exchange yesterday.
The company released 17,861,801 shares yesterday morning at an opening price of $1.47 (92.5p) each, bringing the company’s total market capitalization to nearly $54 million (£34 million).